Cargando…
Reductive Methylation and Mutation of an Anthrax Toxin Fusion Protein Modulates its Stability and Cytotoxicity
We characterized an anti-cancer fusion protein consisting of anthrax lethal factor (LF) and the catalytic domain of Pseudomonas exotoxin A by (i) mutating the N-terminal amino acids and by (ii) reductive methylation to dimethylate all lysines. Dimethylation of lysines was achieved quantitatively and...
Autores principales: | Bachran, Christopher, Gupta, Pradeep K., Bachran, Silke, Leysath, Clinton E., Hoover, Benjamin, Fattah, Rasem J., Leppla, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996465/ https://www.ncbi.nlm.nih.gov/pubmed/24755540 http://dx.doi.org/10.1038/srep04754 |
Ejemplares similares
-
Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins
por: Bachran, C, et al.
Publicado: (2014) -
Anthrax Toxin-Mediated Delivery of the Pseudomonas Exotoxin A Enzymatic Domain to the Cytosol of Tumor Cells via Cleavable Ubiquitin Fusions
por: Bachran, Christopher, et al.
Publicado: (2013) -
Tumor Targeting and Drug Delivery by Anthrax Toxin
por: Bachran, Christopher, et al.
Publicado: (2016) -
Anthrax Edema Factor Toxicity Is Strongly Mediated by the N-end Rule
por: Leysath, Clinton E., et al.
Publicado: (2013) -
An anthrax toxin variant with an improved activity in tumor targeting
por: Wein, Alexander N., et al.
Publicado: (2015)